TGF-beta1 Secreted by Gastric Fibroblasts Up-regulates CD44H Expression and Stimulates the Peritoneal Metastatic Ability of Scirrhous Gastric Cancer Cells

Overview

Journal Int J Oncol

Specialty Oncology

Date 2000 Jan 20

PMID 10639581

Citations 12

Authors

T Koyama

M Yashiro

T Inoue

S Nishimura

Affiliations

Soon will be listed here.

Abstract

Gastric fibroblast-derived conditioned medium and TGF-beta1 stimulated the adhesion ability of scirrhous gastric cancer cells to mesothelial cells, but not that of well-differentiated gastric cancer cells. The CD44H expression of scirrhous gastric cancer cells was significantly up-regulated by gastric fibroblast-derived CM and TGF-beta1. The stimulated adhesion ability and CD44H expression was significantly inhibited by anti TGF-beta1 neutralizing antibody. These findings suggested that TGF-beta1 secreted by gastric fibroblasts up-regulated the CD44H expression of scirrhous gastric cancer cells, which resulted in the stimulation of the adhesion ability of scirrhous gastric cancer cells to the mesothelium, and increased the peritoneal dissemination potential. These results might explain one of the reasons why scirrhous gastric carcinomas develop frequent peritoneal dissemination.

Citing Articles

The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.

Matsuoka T, Yashiro M Biomolecules. 2023; 13(10).

PMID: 37892233 PMC: 10605301. DOI: 10.3390/biom13101551.

Prognosis prediction model for a special entity of gastric cancer, linitis plastica.

Chen X, Zhi Y, Lin Z, Ma J, Mou W, Yu J J Gastrointest Oncol. 2021; 12(2):307-327.

PMID: 34012628 PMC: 8107584. DOI: 10.21037/jgo-20-264.

Crosstalk Between Cancer Associated Fibroblasts and Cancer Cells in Scirrhous Type Gastric Cancer.

Miki Y, Yashiro M, Moyano-Galceran L, Sugimoto A, Ohira M, Lehti K Front Oncol. 2020; 10:568557.

PMID: 33178597 PMC: 7596590. DOI: 10.3389/fonc.2020.568557.

Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil.

Kurata T, Fushida S, Kinoshita J, Oyama K, Yamaguchi T, Okazaki M Cancer Manag Res. 2018; 10:2729-2742.

PMID: 30147370 PMC: 6101023. DOI: 10.2147/CMAR.S167846.

Limited significance of curative surgery in Borrmann type IV gastric cancer.

Kim E, Yoo H, Song K, Park C Med Oncol. 2016; 33(7):69.

PMID: 27251378 DOI: 10.1007/s12032-016-0783-3.